Skip to content
Clinical Trials – home
BioInvent International AB
Sponsor

BioInvent International AB

Sweden Ideongatan 1 A, Lunds Allhelgonafors., 223 62 Lund, Sweden

About the sponsor

Research activity in indolent B-cell non-Hodgkin lymphoma includes relapsed and refractory disease settings, with attention to follicular lymphoma, marginal zone lymphoma, and mantle cell lymphoma.

  • Rituximab-based combinations
  • Acalabrutinib
  • CD32b targeting

The sponsor’s work in this area centres on antibody-based approaches for lymphoma subtypes with limited treatment options.

About Specializations

BioInvent International AB runs clinical trials in conditions such as Neoplasm malignant, Metastatic malignant melanoma, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

5 clinical trials

Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:BioInvent International AB
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Bi-1808
  • Sponsor:BioInvent International AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:BI-1607
  • Sponsor:BioInvent International AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Acalabrutinib
  • Sponsor:BioInvent International AB

Neoplasm malignant

Not recruiting
Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Bi-1910
  • Sponsor:BioInvent International AB

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.